Staphylococcal superantigen-like proteins interact with human MAP kinase signaling protein ERK2.
Debabrata DuttaDevdeep MukherjeeIndranil Arun MukherjeeTapas Kumar MaitiAmit BasakAmit Kumar DasPublished in: FEBS letters (2019)
This study aimed to identify the intracellular binding partner of a unique class of staphylococcal secreted exotoxins called superantigen-like proteins (SSL) from human macrophage and keratinocyte cell lysates. Here, we report that SSL1 specifically binds to human extracellular signal-regulated kinase 2 (hERK2), an important stress-activated kinase in mitogen-activated protein kinase signaling pathways. Western blot and in vitro binding studies with recombinant hERK2 confirmed the binding interaction of SSL1, SSL7, and SSL10 with hERK2. Moreover, the SSLs-hERK2 interaction was validated biochemically by ELISA. Our finding shows that SSLs play a novel role by binding with host cell MAP kinase signaling pathway protein. Understanding the SSL-hERK2 interaction will also provide a basis for designing SSL-based peptide inhibitors of hERK2 in cancer therapy.
Keyphrases
- signaling pathway
- endothelial cells
- protein kinase
- tyrosine kinase
- pi k akt
- induced pluripotent stem cells
- binding protein
- cancer therapy
- staphylococcus aureus
- single cell
- pluripotent stem cells
- cell therapy
- dna binding
- cell proliferation
- transcription factor
- adipose tissue
- methicillin resistant staphylococcus aureus
- mesenchymal stem cells
- stress induced
- amino acid
- endoplasmic reticulum stress
- human immunodeficiency virus
- antiretroviral therapy